Politics Law

More

  • Soaring drug prices: What can Congress do? Thursday, 4 Feb 2016 | 1:02 PM ET
    Soaring drug prices: What can Congress do?

    CNBC's Eamon Javers reports on government involvement in drug prices.

  • Op-Ed: THIS is the weak link in global security Thursday, 4 Feb 2016 | 12:46 PM ET
    A Spanish Guardia Civil boat patrol the water.

    In an age of terror, its high time that global leaders get this unregulated industry under control, says Ami Daniel.

  • Duncan on Shkreli: Never seen such arrogance Thursday, 4 Feb 2016 | 10:37 AM ET
    Rep. Duncan on Shkreli: Never seen such arrogance

    Former Turing Pharmaceuticals CEO Martin Shkreli was escorted from a drug price hike hearing after pleading the Fifth Amendment. CNBC's Meg Tirrell reports on comments by Rep. John Duncan (R-Tenn.) on Shkreli's what he calls "arrogance."

  • Shkreli tweets after pleading Fifth Thursday, 4 Feb 2016 | 10:20 AM ET
    Shkreli tweets after pleading Fifth

    Former Turing Pharmaceuticals CEO Martin Shkreli has tweeted after being excused from a drug price hearing on Capitol Hill. He says "it is hard to accept that these imbeciles represent the people in our government."

  • Drug prices debate Thursday, 4 Feb 2016 | 10:12 AM ET
    Drug prices debate

    CNBC's Meg Tirrell reports from Capitol Hill, where former Turing Pharmaceuticals CEO Martin Shkreli's invoked the Fifth Amendment at a drug price hike hearing.

  • Rep. Gowdy to Shkreli's attorney: You will be seated Thursday, 4 Feb 2016 | 10:06 AM ET
    Rep. Gowdy to Shkreli's attorney: You wil be seated

    Former Turing Pharmaceuticals CEO Martin Shkreli pleads the Fifth Amendment before Congress, and Shkreli's Attorney Benjamin Brafman attempts to address Congress.

  • Attorney: No disrespect, just 'nervous energy' by Shkreli

    Former Turing Pharmaceuticals CEO Martin Shkreli's Attorney Benjamin Brafman speaks to the press after Shkreli was excused from a House panel hearing.

  • Jim Cramer on Brafman's attempt: My breath is taken away

    Martin Shkreli's Attorney Benjamin Brafman attempted to address Congress in a hearing on drug price hikes, in which he was told to be seated. CNBC's Jim Cramer weighs in.

  • Martin Shkreli excused from hearing Thursday, 4 Feb 2016 | 9:54 AM ET
    Martin Shkreli excused from hearing

    Former Turing Pharmaceuticals CEO Martin Shkreli is escorted out after pleading the Fifth Amendment in his testimony before the House Oversight Committee hearing on drug price hikes.

  • Cummings to Shkreli: You could change the system Thursday, 4 Feb 2016 | 9:49 AM ET
    Cummings to Shkreli: You could change the system, are you listening?

    Rep. Elijah Cummings presses former Turing Pharmaceuticals CEO Martin Shkreli on Capitol Hill, as he testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.

  • Shkreli pleads the Fifth Thursday, 4 Feb 2016 | 9:41 AM ET
    Martin Shkreli, former CEO of Turing Pharmaceuticals LLC, is sworn in before a House Oversight and Government Reform hearing on "Developments in the Prescription Drug Market Oversight" on Capitol Hill in Washington February 4, 2016.

    Former Turing Pharmaceuticals CEO Martin Shkreli testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.

  • Congress presses Martin Shkreli on drug prices Thursday, 4 Feb 2016 | 9:40 AM ET
    Congress presses Martin Shkreli on drug prices

    Former Turing Pharmaceuticals CEO Martin Shkreli testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.

  • Martin Shkreli on the Hill Thursday, 4 Feb 2016 | 9:20 AM ET
    Martin Shkreli on the Hill

    House Oversight Chairman Jason Chaffetz swears in the panel at the House Oversight Committee hearing on drug price hikes, where former Turing Pharmaceuticals CEO Martin Shkreli is testifying.

  • Jim Cramer: Drug price hearing 'not for show' Thursday, 4 Feb 2016 | 9:06 AM ET
    Jim Cramer: Drug price hearing 'not for show'

    The "Squawk on the Street" crew discuss the House Oversight Committee hearing on drug price hikes, where former Turing Pharmaceuticals CEO Martin Shkreli, and Valeant Pharmaceuticals interim CEO Howard Schiller are testifying.

  • How is regulation affecting Daimler? Thursday, 4 Feb 2016 | 5:29 AM ET
    How is regulation affecting Daimler?

    Dieter Zetsche, CEO of Daimler, talks about designing fuel-efficient cars to meet regulatory requirements.

  • NZ Trade Min: These are the key benefits of TPP Thursday, 4 Feb 2016 | 1:07 AM ET
    TPP Best agreement NZ has signed

    John McClay, New Zealand's Trade Minister, outlines the advantages of the Trans-Pacific Partnership deal, which took 7 years to negotiate.

  • Why TPP is a win for New Zealand Thursday, 4 Feb 2016 | 12:52 AM ET
    TPP impact on NZ

    The real prize from the TPP deal is access to markets including the U.S. and Japan, says Mike Petersen, New Zealand Special Agricultural Trade Envoy.

  • Aussie TradeMin casts doubts on World Bank report Wednesday, 3 Feb 2016 | 8:52 PM ET
    Aussie TradeMin casts doubts on World Bank report

    Australia's Trade Minister Andrew Robb doubts the World Bank's economic metrics that suggest that the TPP deal might not be as beneficial as expected.

  • Will the TPP deal deliver big returns? Wednesday, 3 Feb 2016 | 9:59 PM ET
    TPP analysis

    The TPP deal contains some huge structural changes and long-term benefits to its members, says Principal Global Investor's Bob Baur.

  • Uphill task to get TPP deal ratified: Advisor Wednesday, 3 Feb 2016 | 8:03 PM ET
    TPP Impact on US

    Eric Shimp, policy advisor at Alston & Bird, outlines several factors that will make Congress taifying the TPP deal a real challenge.

Contact Law

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.